ShangPharma, Icahn in R&D deal

ShangPharma Innovation Inc. (South San Francisco, Calif.) will fund preclinical research at the Icahn School of Medicine at Mount Sinai (New York, N.Y.) to validate drug targets and discover drug candidates. ShangPharma Innovation said the partners will share in profits for resulting therapeutics, but declined to disclose financial terms...